RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007–2014

        Xiaomeng Yue,Jane M. Pruemer,Ana L. Hincapie,Ziyad S. Almalki,Jeff J. Guo 대한부인종양학회 2020 Journal of Gynecologic Oncology Vol.31 No.4

        Objective: This study estimated nationally representative medical expenditures ofgynecologic cancers, described treatment patterns and assessed key risk factors associatedwith the economic burden in the United States. Methods: A retrospective repeated measures design was used to estimate the effect ofgynecologic cancers on medical expenditures and utilization among women. Data wereextracted from the Medical Expenditure Panel Survey (weighted sample of 609,787 US adults)from 2007 to 2014. Using the behavioral model of health services utilization, characteristicsof cancer patients were examined and compared among uterine, cervical, and ovarian cancerpatients. Multivariable linear regression models were conducted on medical expenditure witha prior logarithmic transformation. Results: The estimated annual medical expenditure attributed to gynecologic cancers was$3.8 billion, with an average cost of $6,293 per patient. The highest annual cost per personwas ovarian cancer ($13,566), followed by uterine cancer ($6,852), and cervical cancer($2,312). The major components of medical costs were hospital inpatient stays (53%, $2.03billion), followed by office-based visits (15%, $559 million), and outpatient visits (13%, $487million). Two key prescription expenditures were antineoplastic hormones (10.3%) andanalgesics (9.2%). High expenditures were significantly associated with being a marriedwoman (p<0.001), having private health insurance (p<0.001), being from a low- and middle income family (p<0.001), or living in the Midwest or the South (p<0.001). Conclusion: The key risk factors and components were well described for the economicburden of gynecologic cancers. With a growing population of cancer patients, efforts toreduce the burden of gynecologic cancers are warranted.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼